BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37906252)

  • 1. Signaling metabolite succinylacetone activates HIF-1α and promotes angiogenesis in GSTZ1-deficient hepatocellular carcinoma.
    Luo H; Wang Q; Yang F; Liu R; Gao Q; Cheng B; Lin X; Huang L; Chen C; Xiang J; Wang K; Qin B; Tang N
    JCI Insight; 2023 Oct; 8(23):. PubMed ID: 37906252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMP9-ID1 Signaling Activates HIF-1α and VEGFA Expression to Promote Tumor Angiogenesis in Hepatocellular Carcinoma.
    Chen H; Nio K; Tang H; Yamashita T; Okada H; Li Y; Doan PTB; Li R; Lv J; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
    Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
    J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
    Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
    J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma.
    Wen Y; Zhou X; Lu M; He M; Tian Y; Liu L; Wang M; Tan W; Deng Y; Yang X; Mayer MP; Zou F; Chen X
    Oncogene; 2019 Mar; 38(11):1845-1859. PubMed ID: 30367150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma.
    Zhou L; Zhao Y; Pan LC; Wang J; Shi XJ; Du GS; He Q
    World J Gastroenterol; 2022 Aug; 28(32):4600-4619. PubMed ID: 36157928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA PAARH promotes hepatocellular carcinoma progression and angiogenesis via upregulating HOTTIP and activating HIF-1α/VEGF signaling.
    Wei H; Xu Z; Chen L; Wei Q; Huang Z; Liu G; Li W; Wang J; Tang Q; Pu J
    Cell Death Dis; 2022 Feb; 13(2):102. PubMed ID: 35110549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
    Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
    Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.
    Hou P; Kuo CY; Cheng CT; Liou JP; Ann DK; Chen Q
    PLoS One; 2014; 9(11):e113865. PubMed ID: 25420025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epigallocatechin gallate derivative Y
    Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
    J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIPK2 suppresses tumor growth and progression of hepatocellular carcinoma through promoting the degradation of HIF-1α.
    Chen P; Duan X; Li X; Li J; Ba Q; Wang H
    Oncogene; 2020 Apr; 39(14):2863-2876. PubMed ID: 32034309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSTZ1-1 Deficiency Activates NRF2/IGF1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone.
    Yang F; Li J; Deng H; Wang Y; Lei C; Wang Q; Xiang J; Liang L; Xia J; Pan X; Li X; Long Q; Chang L; Xu P; Huang A; Wang K; Tang N
    EMBO J; 2019 Aug; 38(15):e101964. PubMed ID: 31267557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canagliflozin Modulates Hypoxia-Induced Metastasis, Angiogenesis and Glycolysis by Decreasing HIF-1α Protein Synthesis via AKT/mTOR Pathway.
    Luo J; Sun P; Zhang X; Lin G; Xin Q; Niu Y; Chen Y; Xu N; Zhang Y; Xie W
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SiRNA-HIF-1α delivered by attenuated Salmonella enhances the efficacy of Lenvatinib against hepatocellular carcinoma.
    Chen P; Wang Y; Zhu X; Huang Y; Chen J; Sun H; Wang Y; Zhao S; You Y; Wu Y; Yang T; Wei T; Duan X; Zhao T; Jia H; Ren J
    Int Immunopharmacol; 2024 Mar; 130():111728. PubMed ID: 38430801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
    Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
    J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. γ-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1α/VEGF pathways under hypoxic condition.
    Xiao H; Tong R; Ding C; Lv Z; Du C; Peng C; Cheng S; Xie H; Zhou L; Wu J; Zheng S
    Oncotarget; 2015 Feb; 6(4):2180-92. PubMed ID: 25537504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine Promotes Angiogenesis and Vasculogenic Mimicry in Human Hepatocellular Carcinoma through α
    Fang T; Lin L; Ye ZJ; Fang L; Shi S; Yu KD; Miao HH; Li TZ
    Biomed Environ Sci; 2022 Oct; 35(10):931-942. PubMed ID: 36443270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target.
    Lin D; Wu J
    World J Gastroenterol; 2015 Nov; 21(42):12171-8. PubMed ID: 26576101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.